As of 2025-09-15, the Relative Valuation of Albireo Pharma Inc (ALBO) is (53.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -220.6%.
The range of the Relative Valuation is (42.48) - (69.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 11.1x | 7.7x |
| Forward P/E multiples | 6.7x - 11.6x | 9.1x |
| Fair Price | (42.48) - (69.92) | (53.26) |
| Upside | -196.2% - -258.4% | -220.6% |
| Date | P/E |